Wendy Covert

618 total citations
5 papers, 299 citations indexed

About

Wendy Covert is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Wendy Covert has authored 5 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Hematology and 2 papers in Oncology. Recurrent topics in Wendy Covert's work include Acute Myeloid Leukemia Research (3 papers), Neutropenia and Cancer Infections (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Wendy Covert is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Neutropenia and Cancer Infections (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Wendy Covert collaborates with scholars based in United States. Wendy Covert's co-authors include Marina Konopleva, Naval Daver, Caitlin R. Rausch, Farhad Ravandi, Christopher B. Benton, Guillermo Garcia‐Manero, Nitin Jain, Courtney D. DiNardo, Kayleigh Marx and Elias Jabbour and has published in prestigious journals such as Blood, American Journal of Hematology and Antibodies.

In The Last Decade

Wendy Covert

4 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy Covert United States	3	236	143	80	62	55	5	299
Curtis A. Lachowiez United States	10	267 1.1×	168 1.2×	48 0.6×	88 1.4×	53 1.0×	35	319
Jan Davisson United States	6	333 1.4×	228 1.6×	52 0.7×	120 1.9×	93 1.7×	8	451
Micol Quaresima Italy	6	231 1.0×	122 0.9×	80 1.0×	44 0.7×	71 1.3×	11	262
Marion Loirat France	7	142 0.6×	60 0.4×	81 1.0×	24 0.4×	25 0.5×	8	189
Eisaku Iwanaga Japan	8	122 0.5×	70 0.5×	20 0.3×	47 0.8×	42 0.8×	19	179
Kira Behrens Australia	7	161 0.7×	166 1.2×	36 0.5×	50 0.8×	27 0.5×	10	300
Jiejing Qian China	10	162 0.7×	74 0.5×	46 0.6×	28 0.5×	59 1.1×	22	231
Ulrich Duehrsen Germany	7	85 0.4×	43 0.3×	125 1.6×	72 1.2×	17 0.3×	32	243
James H. Jerkins United States	9	164 0.7×	33 0.2×	72 0.9×	32 0.5×	43 0.8×	27	226
J Jaubert France	7	187 0.8×	57 0.4×	137 1.7×	66 1.1×	84 1.5×	8	312

Countries citing papers authored by Wendy Covert

Since Specialization

Citations

This map shows the geographic impact of Wendy Covert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Covert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Covert more than expected).

Fields of papers citing papers by Wendy Covert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Covert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Covert. The network helps show where Wendy Covert may publish in the future.

Co-authorship network of co-authors of Wendy Covert

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Covert. A scholar is included among the top collaborators of Wendy Covert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Covert. Wendy Covert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Covert, Wendy & Jane E. Rogers. (2025). Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma. Antibodies. 14(1). 26–26.

2.

Rogers, Jane E., Cheuk Hong Leung, Van Du Nguyen, et al.. (2024). Direct Clinical Pharmacist-Patient Telephone Follow-Up: A Focus on GI Medical Oncology Symptom Management. JCO Oncology Practice. 20(6). 808–815. 1 indexed citations

3.

DiNardo, Courtney D., Caitlin R. Rausch, Christopher B. Benton, et al.. (2017). Clinical experience with the BCL2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. American Journal of Hematology. 93(3). 401–407. 293 indexed citations

4.

Rausch, Caitlin R., Courtney D. DiNardo, Tapan M. Kadia, et al.. (2017). Results of Off-Label Venetoclax Use in Combination with Low-Intensity Chemotherapy in Patients with Relapsed and Refractory Myeloid Malignancies. Blood. 130. 1356–1356. 3 indexed citations

5.

Covert, Wendy, et al.. (2010). Incidence of myelodysplastic syndromes in patients receiving concurrent myelosuppressive chemotherapy and pegfilgrastim. Journal of Oncology Pharmacy Practice. 17(4). 366–371. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact